Factores pronósticos de fracaso terapéutico al radioyodo en enfermedad de Graves

Novik A., Victoria; Villalobos M., Camila; Torrejón A., Ignacio; Opazo R., Claudio; Jouanne F., Eugenio; Martínez L., Felipe.
Rev. chil. endocrinol. diabetes ; 5(2): 62-67, abr. 2012. tab, graf
Artículo en Español | LILACS | ID: lil-640615

Documentos relacionados

  1. Thyroid volume is the key predictor of hyperthyroidism remission after radioactive iodine therapy in pediatric patients.
  2. Effect tracking of <sup>131</sup>I treatment in Graves' hyperthyroidism patients within 1 year and analysis of the factors that may influence the cure.
  3. Radioactive Iodine Therapy of Graves' Disease in Patients Pretreated With Methimazole Without Radioiodine Uptake for Dose Estimation.
  4. Long-term outcome and prognostic factors of single-dose Radioiodine Therapy in patients with Graves' disease.
  5. Prospective study to evaluate radioactive iodine of 20 mCi vs 10-15 mCi in Graves' disease.
  6. Age moderates the associations between TRAbs, free T3 and outcomes of Graves' disease patients with radioactive iodine treatment.
  7. Futility: Definition and Goals.
  8. Radioiodine uptake after monotherapy with potassium iodide in patients with Graves' disease.
  9. Long-Term Outcomes of Radioiodine Therapy for Juvenile Graves Disease with Emphasis on Subsequently Detected Thyroid Nodules: A Single Institution Experience from Japan.
  10. Criterialism versus Deliberativism.